| Year |
Citation |
Score |
| 2024 |
Sundby LJ, Southern WM, Sun J, Patrinostro X, Zhang W, Yong J, Ervasti JM. Deletion of exons 2 and 3 from Actb and cell immortalization lead to widespread, β-actin independent alterations in gene expression associated with cell cycle control. European Journal of Cell Biology. 103: 151397. PMID 38387258 DOI: 10.1016/j.ejcb.2024.151397 |
0.32 |
|
| 2023 |
Duvick L, Southern WM, Benzow K, Handler HP, Mitchell JS, Kuivinen H, Gadiparthi UK, Yang P, Soles A, Scheeler C, Rainwater O, Shannah S, Larson E, Nichols-Meade T, You Y, ... ... Ervasti JM, et al. Regional vulnerability in a neurodegenerative disease: Delineating SCA1 CNS and muscle therapeutic targets using a conditional mutant ATXN1 mouse. Biorxiv : the Preprint Server For Biology. PMID 36798410 DOI: 10.1101/2023.02.08.527710 |
0.321 |
|
| 2022 |
Guhathakurta P, Carter AL, Thompson AR, Kurila D, LaFrence J, Zhang L, Trask JR, Vanderheyden B, Muretta JM, Ervasti JM, Thomas DD. Enhancing interaction of actin and actin-binding domain 1 of dystrophin with modulators: toward improved gene therapy for Duchenne muscular dystrophy. The Journal of Biological Chemistry. 102675. PMID 36372234 DOI: 10.1016/j.jbc.2022.102675 |
0.353 |
|
| 2022 |
Ramirez MP, Anderson MJM, Kelly MD, Sundby LJ, Hagerty AR, Wenthe SJ, Odde DJ, Ervasti JM, Gordon WR. Dystrophin missense mutations alter focal adhesion tension and mechanotransduction. Proceedings of the National Academy of Sciences of the United States of America. 119: e2205536119. PMID 35700360 DOI: 10.1073/pnas.2205536119 |
0.371 |
|
| 2022 |
Sundby LJ, Southern WM, Hawbaker KM, Trujillo JM, Perrin BJ, Ervasti JM. Nucleotide- and Protein-Dependent Functions of . Molecular Biology of the Cell. mbcE22020054. PMID 35594181 DOI: 10.1091/mbc.E22-02-0054 |
0.362 |
|
| 2020 |
Nelson DM, Fasbender EK, Jakubiak MC, Lindsay A, Lowe DA, Ervasti JM. Rapid, redox-mediated mechanical susceptibility of the cortical microtubule lattice in skeletal muscle. Redox Biology. 37: 101730. PMID 33002761 DOI: 10.1016/J.Redox.2020.101730 |
0.508 |
|
| 2020 |
Ryan TE, Schmidt CA, Tarpey MD, Amorese AJ, Yamaguchi D, Goldberg E, Iñigo MR, Karnekar R, O'Rourke AR, Ervasti JM, Brophy P, Green T, Neufer PD, Fisher-Wellman KH, Spangenburg E, et al. PFKFB3 mediated glycolysis rescues myopathic outcomes in the ischemic limb. Jci Insight. PMID 32841216 DOI: 10.1172/Jci.Insight.139628 |
0.458 |
|
| 2020 |
Lindsay A, Baumann CW, Rebbeck RT, Yuen SL, Southern WM, Hodges JS, Cornea RL, Thomas DD, Ervasti JM, Lowe DA. Mechanical factors tune the sensitivity of mdx muscle to eccentric strength loss and its protection by antioxidant and calcium modulators. Skeletal Muscle. 10: 3. PMID 32007101 DOI: 10.1186/S13395-020-0221-2 |
0.464 |
|
| 2020 |
Ramirez Lopez MP, Rajaganapathy S, Gordon WR, Salapaka MV, Ervasti JM. The Mechanical Properties of a Utrophin Construct Encoding the Tandem CH Actin Binding Domain through Spectrin Repeat 3 is Altered by the Cell Expression System through Post-Translational Modifications Biophysical Journal. 118: 257a-258a. DOI: 10.1016/J.Bpj.2019.11.1497 |
0.36 |
|
| 2019 |
Lindsay A, Southern WM, McCourt PM, Larson AA, Hodges JS, Lowe DA, Ervasti JM. Variable cytoplasmic actin expression impacts the sensitivity of different dystrophin-deficient mdx skeletal muscles to eccentric contraction. The Febs Journal. PMID 30942954 DOI: 10.1111/Febs.14831 |
0.489 |
|
| 2019 |
Rajaganapathy S, McCourt JL, Ghosal S, Lindsay A, McCourt PM, Lowe DA, Ervasti JM, Salapaka MV. Distinct mechanical properties in homologous spectrin-like repeats of utrophin. Scientific Reports. 9: 5210. PMID 30914715 DOI: 10.1038/S41598-019-41569-4 |
0.453 |
|
| 2019 |
Randazzo D, Khalique U, Belanto JJ, Kenea A, Talsness DM, Olthoff JT, Tran MD, Zaal KJ, Pak K, Pinal-Fernandez I, Mammen AL, Sackett D, Ervasti JM, Ralston E. Persistent upregulation of the β-tubulin tubb6, linked to muscle regeneration, is a source of microtubule disorganization in dystrophic muscle. Human Molecular Genetics. PMID 30753428 DOI: 10.1093/Hmg/Ddz035 |
0.817 |
|
| 2018 |
Lindsay A, Larson AA, Verma M, Ervasti JM, Lowe DA. Isometric resistance training increases strength and alters histopathology of dystrophin-deficient mouse skeletal muscle. Journal of Applied Physiology (Bethesda, Md. : 1985). PMID 30571283 DOI: 10.1152/Japplphysiol.00948.2018 |
0.463 |
|
| 2018 |
Randazzo D, Khalique U, Belanto JJ, Kenea A, Talsness DM, Olthoff JT, Tran MD, Zaal KJ, Pak K, Pinal-Fernandez I, Mammen AL, Sackett D, Ervasti JM, Ralston E. Persistent upregulation of the β-tubulin tubb6, linked to muscle regeneration, is a source of microtubule disorganization in dystrophic muscle. Human Molecular Genetics. PMID 30535187 DOI: 10.1093/hmg/ddy418 |
0.817 |
|
| 2018 |
Olthoff JT, Lindsay A, Abo-Zahrah R, Baltgalvis KA, Patrinostro X, Belanto JJ, Yu DY, Perrin BJ, Garry DJ, Rodney GG, Lowe DA, Ervasti JM. Loss of peroxiredoxin-2 exacerbates eccentric contraction-induced force loss in dystrophin-deficient muscle. Nature Communications. 9: 5104. PMID 30504831 DOI: 10.1038/S41467-018-07639-3 |
0.797 |
|
| 2018 |
Lindsay A, Chamberlain CM, Witthuhn BA, Lowe DA, Ervasti JM. Dystrophinopathy associated dysfunction of Krebs cycle metabolism. Human Molecular Genetics. PMID 30476171 DOI: 10.1093/Hmg/Ddy404 |
0.438 |
|
| 2018 |
Le S, Yu M, Hovan L, Zhao Z, Ervasti J, Yan J. Dystrophin As A Molecular Shock Absorber. Acs Nano. PMID 30457830 DOI: 10.1021/Acsnano.8B05721 |
0.475 |
|
| 2018 |
Lindsay A, McCourt PM, Karachunski P, Lowe DA, Ervasti JM. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy. Free Radical Biology & Medicine. PMID 30312761 DOI: 10.1016/J.Freeradbiomed.2018.10.404 |
0.475 |
|
| 2018 |
Strakova J, Kamdar F, Kulhanek D, Razzoli M, Garry DJ, Ervasti JM, Bartolomucci A, Townsend D. Integrative effects of dystrophin loss on metabolic function of the mdx mouse. Scientific Reports. 8: 13624. PMID 30206270 DOI: 10.1038/S41598-018-31753-3 |
0.442 |
|
| 2018 |
Patrinostro X, Roy P, Lindsay A, Chamberlain CM, Sundby LJ, Starker CG, Voytas DF, Ervasti JM, Perrin BJ. Essential nucleotide- and protein-dependent functions of /β-actin. Proceedings of the National Academy of Sciences of the United States of America. PMID 30012594 DOI: 10.1073/Pnas.1807895115 |
0.447 |
|
| 2018 |
Nelson DM, Lindsay A, Judge LM, Duan D, Chamberlain JS, Lowe DA, Ervasti JM. Variable rescue of microtubule and physiological phenotypes in mdx muscle expressing different miniaturized dystrophins. Human Molecular Genetics. PMID 29901725 DOI: 10.1093/hmg/ddy209 |
0.378 |
|
| 2018 |
Lindsay A, Schmiechen A, Chamberlain CM, Ervasti JM, Lowe DA. Neopterin/7,8-dihydroneopterin is elevated in Duchenne muscular dystrophy patients and protects mdx skeletal muscle function. Experimental Physiology. PMID 29791760 DOI: 10.1113/Ep087031 |
0.441 |
|
| 2018 |
Nelson DM, Lindsay A, Judge LM, Duan D, Chamberlain JS, Lowe DA, Ervasti JM. Variable rescue of microtubule and physiological phenotypes in mdx muscle expressing different miniaturized dystrophins. Human Molecular Genetics. PMID 29618008 DOI: 10.1093/Hmg/Ddy113 |
0.532 |
|
| 2018 |
Lindsay A, Ervasti JM, Lowe DA. Isometric Training Increases Strength and Improves Pathophysiology of Dystrophic Skeletal Muscle Medicine & Science in Sports & Exercise. 50: 643. DOI: 10.1249/01.Mss.0000537210.55925.22 |
0.387 |
|
| 2017 |
O'Rourke AR, Lindsay A, Tarpey MD, Yuen S, McCourt P, Nelson DM, Perrin BJ, Thomas DD, Spangenburg EE, Lowe DA, Ervasti JM. Impaired muscle relaxation and mitochondrial fission associated with genetic ablation of cytoplasmic actin isoforms. The Febs Journal. PMID 29265728 DOI: 10.1111/Febs.14367 |
0.512 |
|
| 2017 |
McCourt JL, Talsness DM, Lindsay A, Arpke RW, Chatterton PD, Nelson DM, Chamberlain CM, Olthoff JT, Belanto JJ, McCourt PM, Kyba M, Lowe DA, Ervasti JM. Mouse models of two missense mutations in actin binding domain 1 of dystrophin associated with Duchenne or Becker muscular dystrophy. Human Molecular Genetics. PMID 29194514 DOI: 10.1093/Hmg/Ddx414 |
0.804 |
|
| 2017 |
Patrinostro X, O'Rourke AR, Chamberlain CM, Moriarity BS, Perrin BJ, Ervasti JM. Relative importance of βcyto- and γcyto-actin in primary mouse embryonic fibroblasts. Molecular Biology of the Cell. PMID 28077619 DOI: 10.1091/Mbc.E16-07-0503 |
0.466 |
|
| 2016 |
Belanto JJ, Olthoff JT, Mader TL, Chamberlain CM, Nelson DM, McCourt PM, Talsness DM, Gundersen GG, Lowe DA, Ervasti JM. Independent variability of microtubule perturbations associated with dystrophinopathy. Human Molecular Genetics. 25: 4951-4961. PMID 28171583 DOI: 10.1093/Hmg/Ddw318 |
0.827 |
|
| 2016 |
Wu XS, Lee SH, Sheng J, Zhang Z, Zhao WD, Wang D, Jin Y, Charnay P, Ervasti JM, Wu LG. Actin Is Crucial for All Kinetically Distinguishable Forms of Endocytosis at Synapses. Neuron. PMID 27840001 DOI: 10.1016/J.Neuron.2016.10.014 |
0.374 |
|
| 2016 |
Belanto JJ, Olthoff JT, Mader TL, Chamberlain CM, Nelson DM, McCourt PM, Talsness DM, Gunderson GG, Lowe DA, Ervasti JM. Independent variability of microtubule perturbations associated with dystrophinopathy. Human Molecular Genetics. PMID 27638889 DOI: 10.1093/hmg/ddw318 |
0.828 |
|
| 2016 |
Dandapat A, Perrin BJ, Cabelka C, Razzoli M, Ervasti JM, Bartolomucci A, Lowe DA, Kyba M. High Frequency Hearing Loss and Hyperactivity in DUX4 Transgenic Mice. Plos One. 11: e0151467. PMID 26978271 DOI: 10.1371/Journal.Pone.0151467 |
0.451 |
|
| 2016 |
Olthoff JT, Belanto JJ, Lindsay A, Rodney GG, Lowe DA, Ervasti JM. Peroxiredoxin II Deficiency Contributes to Contraction-Induced Force Loss in the mdx Model of Duchenne Muscular Dystrophy Free Radical Biology and Medicine. 100: S107. DOI: 10.1016/J.Freeradbiomed.2016.10.273 |
0.811 |
|
| 2015 |
Filareto A, Rinaldi F, Arpke RW, Darabi R, Belanto JJ, Toso EA, Miller AZ, Ervasti JM, McIvor RS, Kyba M, Perlingeiro RC. Pax3-induced expansion enables the genetic correction of dystrophic satellite cells. Skeletal Muscle. 5: 36. PMID 26504514 DOI: 10.1186/S13395-015-0061-7 |
0.786 |
|
| 2015 |
Talsness DM, Belanto JJ, Ervasti JM. Disease-proportional proteasomal degradation of missense dystrophins. Proceedings of the National Academy of Sciences of the United States of America. PMID 26392559 DOI: 10.1073/Pnas.1508755112 |
0.79 |
|
| 2015 |
McCourt JL, Rhett KK, Jaeger MA, Belanto JJ, Talsness DM, Ervasti JM. In vitro stability of therapeutically relevant, internally truncated dystrophins. Skeletal Muscle. 5: 13. PMID 25954502 DOI: 10.1186/S13395-015-0040-Z |
0.781 |
|
| 2015 |
Narayanan P, Chatterton P, Ikeda A, Ikeda S, Corey DP, Ervasti JM, Perrin BJ. Length regulation of mechanosensitive stereocilia depends on very slow actin dynamics and filament-severing proteins. Nature Communications. 6: 6855. PMID 25897778 DOI: 10.1038/Ncomms7855 |
0.425 |
|
| 2015 |
Simionescu-Bankston A, Pichavant C, Canner JP, Apponi LH, Wang Y, Steeds C, Olthoff JT, Belanto JJ, Ervasti JM, Pavlath GK. Creatine kinase B is necessary to limit myoblast fusion during myogenesis. American Journal of Physiology. Cell Physiology. 308: C919-31. PMID 25810257 DOI: 10.1152/Ajpcell.00029.2015 |
0.817 |
|
| 2015 |
Remmers G, Hayden DW, Jaeger MA, Ervasti JM, Valberg SJ. Postanesthetic death in a cat with myopathy. Veterinary Pathology. 52: 186-8. PMID 24577720 DOI: 10.1177/0300985814524797 |
0.343 |
|
| 2015 |
McCourt JL, Rhett KK, Jaeger MA, Belanto JJ, Talsness DM, Ervasti JM. In vitro stability of therapeutically relevant, internally truncated dystrophins Skeletal Muscle. 5. DOI: 10.1186/s13395-015-0040-z. |
0.753 |
|
| 2015 |
Wein N, Vulin A, Simmons T, Gumienny F, Huang N, Muntoni F, Ervasti J, Weiss R, Flanigan K. 60. Intramuscular and Systemic Induction of the N-Truncated Dystrophin By Out-Of-Frame Exon 2 Skipping Restores Muscle Function in the Dup2 Mouse, Providing Further Support for a Therapeutic Pathway for 5’ DMD Mutations Molecular Therapy. 23: S26-S27. DOI: 10.1016/S1525-0016(16)33665-6 |
0.46 |
|
| 2014 |
Belanto JJ, Mader TL, Eckhoff MD, Strandjord DM, Banks GB, Gardner MK, Lowe DA, Ervasti JM. Microtubule binding distinguishes dystrophin from utrophin. Proceedings of the National Academy of Sciences of the United States of America. 111: 5723-8. PMID 24706788 DOI: 10.1073/Pnas.1323842111 |
0.825 |
|
| 2014 |
Vulin A, Wein N, Strandjord DM, Johnson EK, Findlay AR, Maiti B, Howard MT, Kaminoh YJ, Taylor LE, Simmons TR, Ray WC, Montanaro F, Ervasti JM, Flanigan KM. The ZZ domain of dystrophin in DMD: making sense of missense mutations. Human Mutation. 35: 257-64. PMID 24302611 DOI: 10.1002/Humu.22479 |
0.413 |
|
| 2013 |
Johnson EK, Li B, Yoon JH, Flanigan KM, Martin PT, Ervasti J, Montanaro F. Identification of new dystroglycan complexes in skeletal muscle. Plos One. 8: e73224. PMID 23951345 DOI: 10.1371/Journal.Pone.0073224 |
0.496 |
|
| 2013 |
Perrin BJ, Strandjord DM, Narayanan P, Henderson DM, Johnson KR, Ervasti JM. β-Actin and fascin-2 cooperate to maintain stereocilia length. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 8114-21. PMID 23658152 DOI: 10.1523/Jneurosci.0238-13.2013 |
0.69 |
|
| 2013 |
Filareto A, Parker S, Darabi R, Borges L, Iacovino M, Schaaf T, Mayerhofer T, Chamberlain JS, Ervasti JM, McIvor RS, Kyba M, Perlingeiro RC. An ex vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cells. Nature Communications. 4: 1549. PMID 23462992 DOI: 10.1038/Ncomms2550 |
0.393 |
|
| 2013 |
Cheever TR, Ervasti JM. Actin isoforms in neuronal development and function. International Review of Cell and Molecular Biology. 301: 157-213. PMID 23317819 DOI: 10.1016/B978-0-12-407704-1.00004-X |
0.8 |
|
| 2013 |
Johnson EK, Li B, Yoon JH, Flanigan KM, Martin PT, Ervasti JM, Montanaro F. O.3 Identification of novel dystroglycan-associated glycoprotein complexes in skeletal muscle Neuromuscular Disorders. 23: 740. DOI: 10.1016/J.Nmd.2013.06.381 |
0.409 |
|
| 2012 |
Lin AY, Prochniewicz E, Henderson DM, Li B, Ervasti JM, Thomas DD. Impacts of dystrophin and utrophin domains on actin structural dynamics: implications for therapeutic design. Journal of Molecular Biology. 420: 87-98. PMID 22504225 DOI: 10.1016/J.Jmb.2012.04.005 |
0.687 |
|
| 2012 |
Cheever TR, Li B, Ervasti JM. Restricted morphological and behavioral abnormalities following ablation of β-actin in the brain. Plos One. 7: e32970. PMID 22403730 DOI: 10.1371/Journal.Pone.0032970 |
0.805 |
|
| 2012 |
Zhang DS, Piazza V, Perrin BJ, Rzadzinska AK, Poczatek JC, Wang M, Prosser HM, Ervasti JM, Corey DP, Lechene CP. Multi-isotope imaging mass spectrometry reveals slow protein turnover in hair-cell stereocilia. Nature. 481: 520-4. PMID 22246323 DOI: 10.1038/Nature10745 |
0.434 |
|
| 2012 |
Henderson DM, Lin AY, Thomas DD, Ervasti JM. The carboxy-terminal third of dystrophin enhances actin binding activity. Journal of Molecular Biology. 416: 414-24. PMID 22226838 DOI: 10.1016/J.Jmb.2011.12.040 |
0.691 |
|
| 2011 |
Bunnell TM, Ervasti JM. Structural and functional properties of the actin gene family. Critical Reviews in Eukaryotic Gene Expression. 21: 255-66. PMID 22111713 DOI: 10.1615/Critreveukargeneexpr.V21.I3.30 |
0.789 |
|
| 2011 |
Baltgalvis KA, Jaeger MA, Fitzsimons DP, Thayer SA, Lowe DA, Ervasti JM. Transgenic overexpression of γ-cytoplasmic actin protects against eccentric contraction-induced force loss in mdx mice. Skeletal Muscle. 1: 32. PMID 21995957 DOI: 10.1186/2044-5040-1-32 |
0.512 |
|
| 2011 |
Bunnell TM, Burbach BJ, Shimizu Y, Ervasti JM. β-Actin specifically controls cell growth, migration, and the G-actin pool. Molecular Biology of the Cell. 22: 4047-58. PMID 21900491 DOI: 10.1091/Mbc.E11-06-0582 |
0.804 |
|
| 2011 |
Call JA, Ervasti JM, Lowe DA. TAT-μUtrophin mitigates the pathophysiology of dystrophin and utrophin double-knockout mice. Journal of Applied Physiology (Bethesda, Md. : 1985). 111: 200-5. PMID 21565990 DOI: 10.1152/Japplphysiol.00248.2011 |
0.41 |
|
| 2011 |
Henderson DM, Belanto JJ, Li B, Heun-Johnson H, Ervasti JM. Internal deletion compromises the stability of dystrophin. Human Molecular Genetics. 20: 2955-63. PMID 21558423 DOI: 10.1093/Hmg/Ddr199 |
0.783 |
|
| 2011 |
Cheever TR, Olson EA, Ervasti JM. Axonal regeneration and neuronal function are preserved in motor neurons lacking ß-actin in vivo. Plos One. 6: e17768. PMID 21445349 DOI: 10.1371/Journal.Pone.0017768 |
0.788 |
|
| 2011 |
Prins KW, Call JA, Lowe DA, Ervasti JM. Quadriceps myopathy caused by skeletal muscle-specific ablation of β(cyto)-actin. Journal of Cell Science. 124: 951-7. PMID 21325027 DOI: 10.1242/Jcs.079848 |
0.78 |
|
| 2011 |
Lin AY, Prochniewicz E, James Z, Henderson D, Ervasti J, Thomas DD. Structural Dynamics of the Actin-Binding Domains in Dystrophin and Utrophin Biophysical Journal. 100: 302a. DOI: 10.1016/J.Bpj.2010.12.1848 |
0.688 |
|
| 2010 |
Perrin BJ, Sonnemann KJ, Ervasti JM. β-actin and γ-actin are each dispensable for auditory hair cell development but required for Stereocilia maintenance. Plos Genetics. 6: e1001158. PMID 20976199 DOI: 10.1371/Journal.Pgen.1001158 |
0.455 |
|
| 2010 |
Perrin BJ, Ervasti JM. The actin gene family: function follows isoform. Cytoskeleton (Hoboken, N.J.). 67: 630-4. PMID 20737541 DOI: 10.1002/Cm.20475 |
0.427 |
|
| 2010 |
Bunnell TM, Ervasti JM. Delayed embryonic development and impaired cell growth and survival in Actg1 null mice. Cytoskeleton (Hoboken, N.J.). 67: 564-72. PMID 20662086 DOI: 10.1002/Cm.20467 |
0.801 |
|
| 2010 |
Stalnaker SH, Hashmi S, Lim JM, Aoki K, Porterfield M, Gutierrez-Sanchez G, Wheeler J, Ervasti JM, Bergmann C, Tiemeyer M, Wells L. Site mapping and characterization of O-glycan structures on alpha-dystroglycan isolated from rabbit skeletal muscle. The Journal of Biological Chemistry. 285: 24882-91. PMID 20507986 DOI: 10.1074/Jbc.M110.126474 |
0.324 |
|
| 2010 |
Henderson DM, Lee A, Ervasti JM. Disease-causing missense mutations in actin binding domain 1 of dystrophin induce thermodynamic instability and protein aggregation. Proceedings of the National Academy of Sciences of the United States of America. 107: 9632-7. PMID 20457930 DOI: 10.1073/Pnas.1001517107 |
0.658 |
|
| 2010 |
Lin AY, Prochniewicz E, Henderson D, Ervasti J, Thomas DD. Structural Dynamics of the Dystrophin-Actin and Utrophin-Actin Complexes Biophysical Journal. 98: 542a. DOI: 10.1016/J.Bpj.2009.12.2943 |
0.687 |
|
| 2009 |
Prins KW, Humston JL, Mehta A, Tate V, Ralston E, Ervasti JM. Dystrophin is a microtubule-associated protein. The Journal of Cell Biology. 186: 363-9. PMID 19651889 DOI: 10.1083/Jcb.200905048 |
0.758 |
|
| 2009 |
Belyantseva IA, Perrin BJ, Sonnemann KJ, Zhu M, Stepanyan R, McGee J, Frolenkov GI, Walsh EJ, Friderici KH, Friedman TB, Ervasti JM. Gamma-actin is required for cytoskeletal maintenance but not development. Proceedings of the National Academy of Sciences of the United States of America. 106: 9703-8. PMID 19497859 DOI: 10.1073/Pnas.0900221106 |
0.469 |
|
| 2009 |
Sonnemann KJ, Heun-Johnson H, Turner AJ, Baltgalvis KA, Lowe DA, Ervasti JM. Functional substitution by TAT-utrophin in dystrophin-deficient mice. Plos Medicine. 6: e1000083. PMID 19478831 DOI: 10.1371/Journal.Pmed.1000083 |
0.831 |
|
| 2009 |
Prochniewicz E, Henderson D, Ervasti JM, Thomas DD. Dystrophin and utrophin have distinct effects on the structural dynamics of actin. Proceedings of the National Academy of Sciences of the United States of America. 106: 7822-7. PMID 19416869 DOI: 10.1073/Pnas.0812007106 |
0.678 |
|
| 2009 |
Jaeger MA, Sonnemann KJ, Fitzsimons DP, Prins KW, Ervasti JM. Context-dependent functional substitution of alpha-skeletal actin by gamma-cytoplasmic actin. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 23: 2205-14. PMID 19279140 DOI: 10.1096/Fj.09-129783 |
0.756 |
|
| 2009 |
Prochniewicz E, Henderson D, Lin AY, Ervasti J, Thomas DD. Dystrophin and Utrophin have Distinct Effects on the Microsecond Dynamics of Actin Biophysical Journal. 96: 128a-129a. DOI: 10.1016/J.Bpj.2008.12.577 |
0.695 |
|
| 2009 |
Henderson DM, Ervasti JM. Structure Function Analysis of Disease-Causing Missense Mutations in Dystrophin Biophysical Journal. 96: 127a. DOI: 10.1016/J.Bpj.2008.12.567 |
0.673 |
|
| 2008 |
Bunnell TM, Jaeger MA, Fitzsimons DP, Prins KW, Ervasti JM. Destabilization of the dystrophin-glycoprotein complex without functional deficits in alpha-dystrobrevin null muscle. Plos One. 3: e2604. PMID 18596960 DOI: 10.1371/Journal.Pone.0002604 |
0.808 |
|
| 2008 |
Prins KW, Lowe DA, Ervasti JM. Skeletal muscle-specific ablation of gamma(cyto)-actin does not exacerbate the mdx phenotype. Plos One. 3: e2419. PMID 18545671 DOI: 10.1371/Journal.Pone.0002419 |
0.751 |
|
| 2008 |
Ervasti JM, Sonnemann KJ. Biology of the striated muscle dystrophin-glycoprotein complex. International Review of Cytology. 265: 191-225. PMID 18275889 DOI: 10.1016/S0074-7696(07)65005-0 |
0.462 |
|
| 2007 |
Hanft LM, Bogan DJ, Mayer U, Kaufman SJ, Kornegay JN, Ervasti JM. Cytoplasmic gamma-actin expression in diverse animal models of muscular dystrophy. Neuromuscular Disorders : Nmd. 17: 569-74. PMID 17475492 DOI: 10.1016/J.Nmd.2007.03.004 |
0.521 |
|
| 2007 |
Harrison D, Hussain SA, Combs AC, Ervasti JM, Yurchenco PD, Hohenester E. Crystal structure and cell surface anchorage sites of laminin alpha1LG4-5. The Journal of Biological Chemistry. 282: 11573-81. PMID 17307732 DOI: 10.1074/Jbc.M610657200 |
0.338 |
|
| 2007 |
Ervasti JM. Dystrophin, its interactions with other proteins, and implications for muscular dystrophy. Biochimica Et Biophysica Acta. 1772: 108-17. PMID 16829057 DOI: 10.1016/J.Bbadis.2006.05.010 |
0.443 |
|
| 2006 |
Sonnemann KJ, Fitzsimons DP, Patel JR, Liu Y, Schneider MF, Moss RL, Ervasti JM. Cytoplasmic gamma-actin is not required for skeletal muscle development but its absence leads to a progressive myopathy. Developmental Cell. 11: 387-97. PMID 16950128 DOI: 10.1016/J.Devcel.2006.07.001 |
0.536 |
|
| 2006 |
Hanft LM, Rybakova IN, Patel JR, Rafael-Fortney JA, Ervasti JM. Cytoplasmic gamma-actin contributes to a compensatory remodeling response in dystrophin-deficient muscle. Proceedings of the National Academy of Sciences of the United States of America. 103: 5385-90. PMID 16565216 DOI: 10.1073/Pnas.0600980103 |
0.549 |
|
| 2006 |
Rybakova IN, Humston JL, Sonnemann KJ, Ervasti JM. Dystrophin and utrophin bind actin through distinct modes of contact. The Journal of Biological Chemistry. 281: 9996-10001. PMID 16478721 DOI: 10.1074/Jbc.M513121200 |
0.491 |
|
| 2005 |
Combs AC, Ervasti JM. Enhanced laminin binding by alpha-dystroglycan after enzymatic deglycosylation. The Biochemical Journal. 390: 303-9. PMID 15865602 DOI: 10.1042/Bj20050375 |
0.302 |
|
| 2005 |
Rybakova IN, Ervasti JM. Identification of spectrin-like repeats required for high affinity utrophin-actin interaction. The Journal of Biological Chemistry. 280: 23018-23. PMID 15826935 DOI: 10.1074/Jbc.M502530200 |
0.436 |
|
| 2004 |
Ido H, Harada K, Futaki S, Hayashi Y, Nishiuchi R, Natsuka Y, Li S, Wada Y, Combs AC, Ervasti JM, Sekiguchi K. Molecular dissection of the alpha-dystroglycan- and integrin-binding sites within the globular domain of human laminin-10. The Journal of Biological Chemistry. 279: 10946-54. PMID 14701821 DOI: 10.1074/Jbc.M313626200 |
0.312 |
|
| 2003 |
McDearmon EL, Combs AC, Ervasti JM. Core 1 glycans on alpha-dystroglycan mediate laminin-induced acetylcholine receptor clustering but not laminin binding. The Journal of Biological Chemistry. 278: 44868-73. PMID 12952987 DOI: 10.1074/Jbc.M307026200 |
0.303 |
|
| 2003 |
Ervasti JM. Costameres: the Achilles' heel of Herculean muscle. The Journal of Biological Chemistry. 278: 13591-4. PMID 12556452 DOI: 10.1074/Jbc.R200021200 |
0.502 |
|
| 2002 |
Rybakova IN, Patel JR, Davies KE, Yurchenco PD, Ervasti JM. Utrophin binds laterally along actin filaments and can couple costameric actin with sarcolemma when overexpressed in dystrophin-deficient muscle. Molecular Biology of the Cell. 13: 1512-21. PMID 12006649 DOI: 10.1091/Mbc.01-09-0446 |
0.553 |
|
| 2002 |
Warner LE, DelloRusso C, Crawford RW, Rybakova IN, Patel JR, Ervasti JM, Chamberlain JS. Expression of Dp260 in muscle tethers the actin cytoskeleton to the dystrophin-glycoprotein complex and partially prevents dystrophy. Human Molecular Genetics. 11: 1095-105. PMID 11978768 DOI: 10.1093/Hmg/11.9.1095 |
0.533 |
|
| 2002 |
Galkin VE, Orlova A, VanLoock MS, Rybakova IN, Ervasti JM, Egelman EH. The utrophin actin-binding domain binds F-actin in two different modes: implications for the spectrin superfamily of proteins. The Journal of Cell Biology. 157: 243-51. PMID 11956227 DOI: 10.1083/Jcb.200111097 |
0.414 |
|
| 2002 |
Smirnov SP, McDearmon EL, Li S, Ervasti JM, Tryggvason K, Yurchenco PD. Contributions of the LG modules and furin processing to laminin-2 functions. The Journal of Biological Chemistry. 277: 18928-37. PMID 11886875 DOI: 10.1074/Jbc.M201880200 |
0.325 |
|
| 2001 |
McDearmon EL, Combs AC, Ervasti JM. Differential Vicia villosa agglutinin reactivity identifies three distinct dystroglycan complexes in skeletal muscle. The Journal of Biological Chemistry. 276: 35078-86. PMID 11459841 DOI: 10.1074/Jbc.M103843200 |
0.349 |
|
| 2001 |
Orlova A, Rybakova IN, Prochniewicz E, Thomas DD, Ervasti JM, Egelman EH. Binding of dystrophin's tandem calponin homology domain to F-actin is modulated by actin's structure. Biophysical Journal. 80: 1926-31. PMID 11259305 DOI: 10.1016/S0006-3495(01)76162-0 |
0.442 |
|
| 2000 |
Rybakova IN, Patel JR, Ervasti JM. The dystrophin complex forms a mechanically strong link between the sarcolemma and costameric actin. The Journal of Cell Biology. 150: 1209-14. PMID 10974007 DOI: 10.1083/Jcb.150.5.1209 |
0.535 |
|
| 1999 |
Amann KJ, Guo AW, Ervasti JM. Utrophin lacks the rod domain actin binding activity of dystrophin. The Journal of Biological Chemistry. 274: 35375-80. PMID 10585405 DOI: 10.1074/Jbc.274.50.35375 |
0.783 |
|
| 1998 |
Renley BA, Rybakova IN, Amann KJ, Ervasti JM. Dystrophin binding to nonmuscle actin. Cell Motility and the Cytoskeleton. 41: 264-70. PMID 9829780 DOI: 10.1002/(Sici)1097-0169(1998)41:3<264::Aid-Cm7>3.0.Co;2-Z |
0.815 |
|
| 1998 |
Amann KJ, Renley BA, Ervasti JM. A cluster of basic repeats in the dystrophin rod domain binds F-actin through an electrostatic interaction. The Journal of Biological Chemistry. 273: 28419-23. PMID 9774469 DOI: 10.1074/Jbc.273.43.28419 |
0.783 |
|
| 1998 |
McDearmon EL, Burwell AL, Combs AC, Renley BA, Sdano MT, Ervasti JM. Differential heparin sensitivity of alpha-dystroglycan binding to laminins expressed in normal and dy/dy mouse skeletal muscle. The Journal of Biological Chemistry. 273: 24139-44. PMID 9727035 DOI: 10.1074/Jbc.273.37.24139 |
0.46 |
|
| 1997 |
Rybakova IN, Ervasti JM. Dystrophin-glycoprotein complex is monomeric and stabilizes actin filaments in vitro through a lateral association. The Journal of Biological Chemistry. 272: 28771-8. PMID 9353348 DOI: 10.1074/Jbc.272.45.28771 |
0.463 |
|
| 1997 |
Ervasti JM, Burwell AL, Geissler AL. Tissue-specific heterogeneity in alpha-dystroglycan sialoglycosylation. Skeletal muscle alpha-dystroglycan is a latent receptor for Vicia villosa agglutinin b4 masked by sialic acid modification. The Journal of Biological Chemistry. 272: 22315-21. PMID 9268382 DOI: 10.1074/Jbc.272.35.22315 |
0.364 |
|
| 1997 |
Ervasti JM, Rybakova IN, Amann KJ. A multiple site, side binding model for the interaction of dystrophin with F-actin. Society of General Physiologists Series. 52: 31-44. PMID 9210218 |
0.743 |
|
| 1996 |
Rybakova IN, Amann KJ, Ervasti JM. A new model for the interaction of dystrophin with F-actin. The Journal of Cell Biology. 135: 661-72. PMID 8909541 DOI: 10.1083/Jcb.135.3.661 |
0.791 |
|
| 1996 |
Hagstrom JE, Rybakova IN, Staeva T, Wolff JA, Ervasti JM. Nonnuclear DNA binding proteins in striated muscle. Biochemical and Molecular Medicine. 58: 113-21. PMID 8809341 DOI: 10.1006/Bmme.1996.0038 |
0.375 |
|
| 1996 |
Pall EA, Bolton KM, Ervasti JM. Differential heparin inhibition of skeletal muscle alpha-dystroglycan binding to laminins. The Journal of Biological Chemistry. 271: 3817-21. PMID 8631999 DOI: 10.1074/Jbc.271.7.3817 |
0.377 |
|
| 1994 |
Ervasti JM, Roberds SL, Anderson RD, Sharp NJ, Kornegay JN, Campbell KP. Alpha-dystroglycan deficiency correlates with elevated serum creatine kinase and decreased muscle contraction tension in golden retriever muscular dystrophy. Febs Letters. 350: 173-6. PMID 8070559 DOI: 10.1016/0014-5793(94)00748-9 |
0.586 |
|
| 1994 |
Mickelson JR, Ervasti JM, Litterer LA, Campbell KP, Louis CF. Skeletal muscle junctional membrane protein content in pigs with different ryanodine receptor genotypes. The American Journal of Physiology. 267: C282-92. PMID 8048487 DOI: 10.1152/Ajpcell.1994.267.1.C282 |
0.712 |
|
| 1993 |
Roberds SL, Ervasti JM, Anderson RD, Ohlendieck K, Kahl SD, Zoloto D, Campbell KP. Disruption of the dystrophin-glycoprotein complex in the cardiomyopathic hamster. The Journal of Biological Chemistry. 268: 11496-9. PMID 8505286 |
0.366 |
|
| 1993 |
Ervasti JM, Campbell KP. Dystrophin and the membrane skeleton. Current Opinion in Cell Biology. 5: 82-7. PMID 8448034 DOI: 10.1016/S0955-0674(05)80012-2 |
0.597 |
|
| 1993 |
Klietsch R, Ervasti JM, Arnold W, Campbell KP, Jorgensen AO. Dystrophin-glycoprotein complex and laminin colocalize to the sarcolemma and transverse tubules of cardiac muscle. Circulation Research. 72: 349-60. PMID 8418988 DOI: 10.1161/01.Res.72.2.349 |
0.592 |
|
| 1993 |
Matsumura K, Tomé FM, Ionasescu V, Ervasti JM, Anderson RD, Romero NB, Simon D, Récan D, Kaplan JC, Fardeau M. Deficiency of dystrophin-associated proteins in Duchenne muscular dystrophy patients lacking COOH-terminal domains of dystrophin. The Journal of Clinical Investigation. 92: 866-71. PMID 8349821 DOI: 10.1172/Jci116661 |
0.433 |
|
| 1993 |
Ervasti JM, Campbell KP. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. The Journal of Cell Biology. 122: 809-23. PMID 8349731 DOI: 10.1083/Jcb.122.4.809 |
0.585 |
|
| 1993 |
Ervasti JM, Campbell KP. Dystrophin-associated glycoproteins: their possible roles in the pathogenesis of Duchenne muscular dystrophy. Molecular and Cell Biology of Human Diseases Series. 3: 139-66. PMID 8111538 DOI: 10.1007/978-94-011-1528-5_6 |
0.587 |
|
| 1992 |
Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature. 355: 696-702. PMID 1741056 DOI: 10.1038/355696A0 |
0.5 |
|
| 1992 |
Matsumura K, Ervasti JM, Ohlendieck K, Kahl SD, Campbell KP. Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle. Nature. 360: 588-91. PMID 1461282 DOI: 10.1038/360588A0 |
0.63 |
|
| 1991 |
Ervasti JM, Kahl SD, Campbell KP. Purification of dystrophin from skeletal muscle. The Journal of Biological Chemistry. 266: 9161-5. PMID 2026615 |
0.351 |
|
| 1991 |
Ohlendieck K, Ervasti JM, Snook JB, Campbell KP. Dystrophin-glycoprotein complex is highly enriched in isolated skeletal muscle sarcolemma. The Journal of Cell Biology. 112: 135-48. PMID 1986002 DOI: 10.1083/Jcb.112.1.135 |
0.599 |
|
| 1991 |
Ervasti JM, Campbell KP. Membrane organization of the dystrophin-glycoprotein complex. Cell. 66: 1121-31. PMID 1913804 DOI: 10.1016/0092-8674(91)90035-W |
0.556 |
|
| 1991 |
Ervasti JM, Strand MA, Hanson TP, Mickelson JR, Louis CF. Ryanodine receptor in different malignant hyperthermia-susceptible porcine muscles. The American Journal of Physiology. 260: C58-66. PMID 1824808 DOI: 10.1152/Ajpcell.1991.260.1.C58 |
0.649 |
|
| 1991 |
Ohlendieck K, Ervasti JM, Matsumura K, Kahl SD, Leveille CJ, Campbell KP. Dystrophin-related protein is localized to neuromuscular junctions of adult skeletal muscle. Neuron. 7: 499-508. PMID 1654951 DOI: 10.1016/0896-6273(91)90301-F |
0.626 |
|
| 1990 |
Ervasti JM, Ohlendieck K, Kahl SD, Gaver MG, Campbell KP. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature. 345: 315-9. PMID 2188135 DOI: 10.1038/345315A0 |
0.572 |
|
| 1989 |
Ervasti JM, Mickelson JR, Lewis SM, Thomas DD, Louis CF. An electron paramagnetic resonance study of skeletal muscle membrane fluidity in malignant hyperthermia. Biochimica Et Biophysica Acta. 986: 70-4. PMID 2554982 DOI: 10.1016/0005-2736(89)90273-3 |
0.583 |
|
| 1989 |
Ervasti JM, Mickelson JR, Louis CF. Transverse tubule calcium regulation in malignant hyperthermia. Archives of Biochemistry and Biophysics. 269: 497-506. PMID 2537601 DOI: 10.1016/0003-9861(89)90133-1 |
0.581 |
|
| 1989 |
Ervasti JM, Claessens MT, Mickelson JR, Louis CF. Altered transverse tubule dihydropyridine receptor binding in malignant hyperthermia. The Journal of Biological Chemistry. 264: 2711-7. PMID 2536721 |
0.587 |
|
| Show low-probability matches. |
